Eucrates Biomedical Acquisition announced that holders of the units sold in the company’s IPO may elect to separately trade the ordinary shares and redeemable warrants. Those units not separated will continue to trade on the Nasdaq under “EUCRU,” and the ordinary shares and redeemable warrants that are separated will trade under “EUCR” and “EUCRW,” respectively.
The SPAC raised $100 million in an October IPO. Read more.
